| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/18/2010 | WO2010030716A1 Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v |
| 03/18/2010 | WO2010030643A1 Diagnosis and prognosis of immune disorders using stat4 expression |
| 03/18/2010 | WO2010030608A1 Methods for detecting and quantifying oversulfated glycosaminoglycans |
| 03/18/2010 | WO2010030604A2 Methods and compositions for determining and monitoring dietary supplementation |
| 03/18/2010 | WO2010030600A2 Methods and compositions for personalization of dietary supplements based on genetic markers |
| 03/18/2010 | WO2010030425A1 Open-reading-frame (orf) phage display |
| 03/18/2010 | WO2010030365A2 Thyroid tumors identified |
| 03/18/2010 | WO2010030355A2 Targeted chemical high-throughput screening method |
| 03/18/2010 | WO2010030343A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 03/18/2010 | WO2010030293A1 Methods, systems, and compositions for cancer diagnosis |
| 03/18/2010 | WO2010030243A1 Gene sequences for the detection of chikungunya and dengue fever |
| 03/18/2010 | WO2010030171A1 Method for diagnostic marker development |
| 03/18/2010 | WO2010030049A1 Composition for detection of m. tuberculosis complex or mycobacteria genus and simultaneous detection method for m. tuberculosis complex and mycobacteria genus with multiplex real time pcr using the same |
| 03/18/2010 | WO2010030035A1 Impedance spectroscopy measurement of dna |
| 03/18/2010 | WO2010029629A1 Dna-containing ink composition |
| 03/18/2010 | WO2010029548A1 Method for identifying genetic loci invovled in hybrid vigor |
| 03/18/2010 | WO2010029527A1 A method for predicting athletic performance potential |
| 03/18/2010 | WO2010029520A1 Primer and amplification method for forming single stranded dna amplicons |
| 03/18/2010 | WO2010029440A1 Molecular classifier for evaluating the risk of metastasic relapse in breast cancer |
| 03/18/2010 | WO2010029378A2 Anti-protozoa compounds |
| 03/18/2010 | WO2010029360A1 Compositions and methods for the rapid growth and detection of microorganisms |
| 03/18/2010 | WO2010029309A1 Analysis of the size of nucleic acids |
| 03/18/2010 | WO2010029176A1 Genes associated with posttraumatic-stress disorder (ptsd) |
| 03/18/2010 | WO2010029174A2 Method |
| 03/18/2010 | WO2010029170A2 Method for the prognosis and diagnosis of type ii diabetes in critical persons |
| 03/18/2010 | WO2010029167A2 Means and methods for evaluating a therapy with a p38 map kinase inhibitor |
| 03/18/2010 | WO2010028863A1 Method to eliminate polymerase chain reaction inhibitors from faecal samples |
| 03/18/2010 | WO2010028443A1 Microrna target identification assay |
| 03/18/2010 | WO2010010211A3 Disposable amperometric biosensor, production method thereof and method for determining the presence of analytes in foods |
| 03/18/2010 | WO2010009368A3 Compositions for the detection and treatment of colorectal cancer |
| 03/18/2010 | WO2010004591A3 Genetic variants for breast cancer risk assessment |
| 03/18/2010 | WO2010004164A3 Culture medium containing a spore germination inhibiting or delaying compound |
| 03/18/2010 | WO2009158024A3 Microfluidic droplets for metabolic engineering and other applications |
| 03/18/2010 | WO2009155103A3 Compositions for use in identification of tick-borne pathogens |
| 03/18/2010 | WO2009153779A3 Genotyping method and means thereof for use in traceability schemes |
| 03/18/2010 | WO2009153775A3 Methods for distinguishing between specific types of lung cancers |
| 03/18/2010 | WO2009148528A8 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment |
| 03/18/2010 | WO2009146859A3 Methods and compositions in the treatment of coronaviruses |
| 03/18/2010 | WO2009146460A3 Methods for disease therapy |
| 03/18/2010 | WO2009146098A3 Stem cells and uses thereof |
| 03/18/2010 | WO2009138689A3 In vitro detection of antibodies produced following a legionella pneumophila infection |
| 03/18/2010 | WO2009134322A3 Lysine riboswitch and compositions and uses thereof |
| 03/18/2010 | WO2009126804A3 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| 03/18/2010 | WO2009089831A3 Base-modified primer oligomers for multiplex rt-pcr |
| 03/18/2010 | WO2009088442A3 Isomerases and epimerases and methods of using |
| 03/18/2010 | WO2009051672A3 Natural killer immunoglobulin-like receptor (kir) assay |
| 03/18/2010 | WO2008125365A8 Microbial population analysis |
| 03/18/2010 | US20100071095 Method for Generating Plant Diversity By Incorporation of Microsatellite Sequences Into the Plant Genome |
| 03/18/2010 | US20100071091 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 03/18/2010 | US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis |
| 03/18/2010 | US20100070530 Nucleotide Sequence Screening |
| 03/18/2010 | US20100070196 Blood Glucose Tracking Apparatus and Methods |
| 03/18/2010 | US20100070192 Optimization of crossover points for directed evolution |
| 03/18/2010 | US20100070191 Lung Cancer Biomarkers and Uses Thereof |
| 03/18/2010 | US20100070186 Methods of screening for and mapping phenotypic and genotypic variations in cells |
| 03/18/2010 | US20100070184 Method for determining resistance of hiv to protease inhibitor treatment |
| 03/18/2010 | US20100069624 Nucleic Acid Mediated Electron Transfer |
| 03/18/2010 | US20100069611 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 03/18/2010 | US20100069470 Identification of protein biomarkers associated with lymph node metastasis in colorectal cancer |
| 03/18/2010 | US20100069465 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 03/18/2010 | US20100069464 Compositions and methods for modulating activity of capped small rnas |
| 03/18/2010 | US20100069463 Methods for the diagnosis and treatment of affective disorders and cushing's syndromes |
| 03/18/2010 | US20100069462 Mitochondrial function of prohibitin 2 (phb2) |
| 03/18/2010 | US20100069344 Small molecule antagonists of bcl2 family proteins |
| 03/18/2010 | US20100069343 Methods of predicting steroid responsiveness with Il-1RII |
| 03/18/2010 | US20100069334 Diagnostic method |
| 03/18/2010 | US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein |
| 03/18/2010 | US20100069298 Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same |
| 03/18/2010 | US20100069258 Hydrophilic Labels for Biomolecules |
| 03/18/2010 | US20100069255 Method for identifying therapeutical targets in secondary tumors, the use of thereof and means for identifying, labelling and targeting secondary tumors |
| 03/18/2010 | US20100069254 Cell Culture Model for Demyelination/Remyelination |
| 03/18/2010 | US20100069251 Methods for producing embryonic stem cells from parthenogenetic embryos |
| 03/18/2010 | US20100069250 Digital PCR Calibration for High Throughput Sequencing |
| 03/18/2010 | US20100068803 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof |
| 03/18/2010 | US20100068796 Blood Glucose Tracking Apparatus and Methods |
| 03/18/2010 | US20100068756 Method and apparatus for detecting and quantifying bacterial spores on a surface |
| 03/18/2010 | US20100068755 Method and system for detection and/or characterization of a biological particle in a sample |
| 03/18/2010 | US20100068754 Density-based cell detection system |
| 03/18/2010 | US20100068753 Biotin-facilitated transport in gram negative bacteria |
| 03/18/2010 | US20100068752 Novel fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest |
| 03/18/2010 | US20100068751 Method and System for Artifact Reduction |
| 03/18/2010 | US20100068750 Method for fluorometrically determining photosynthesis parameters of photoautotropic organisms, device for carrying out said method and a measurement chamber |
| 03/18/2010 | US20100068749 Optical sensor and method for indicating the age or quality of a natural product |
| 03/18/2010 | US20100068748 Fluorescent Ion Indicators for Cadmium and Lanthanide Ion Detection |
| 03/18/2010 | US20100068747 Generic Assay for Monitoring Endocytosis |
| 03/18/2010 | US20100068746 Diagnosis method for fatty liver disease, diagnosis apparatus, diagnosis program, diagnostic agent, and method for screening for therapeutic agent for fatty liver disease |
| 03/18/2010 | US20100068745 Process and kit for measuring the condition of the fibrinolitic system |
| 03/18/2010 | US20100068744 Method for the purification of heat shock proteins |
| 03/18/2010 | US20100068743 Method for predicting response of cancer patient to anticancer drug treatment |
| 03/18/2010 | US20100068742 Methods |
| 03/18/2010 | US20100068741 Assay system for adenosine triphosphate and creatine kinase |
| 03/18/2010 | US20100068740 Microfluidic device with a cylindrical microchannel and a method for fabricating same |
| 03/18/2010 | US20100068739 PH Tolerant Luciferase |
| 03/18/2010 | US20100068731 Use of N-Myristoyltransferase on Non-Tumor Tissue for Cancer Diagnosis |
| 03/18/2010 | US20100068730 Method for screening anti-cancer compounds inhibiting function of tm4sf5 and anti-cancer composition containing chalcone compounds |
| 03/18/2010 | US20100068723 DNA sequencing and genotyping, proteomics, pathogen detection, diagnostics and biodefense; devices for the interfacing of microchips to various types of modules |
| 03/18/2010 | US20100068722 increase the intensity of the fluorescent signal after nucleic acid sequencing reactions; a modified fluorescent labelled guanine-containing nucleotides which exhibit enhanced fluorophore intensity |
| 03/18/2010 | US20100068721 Method and system for protection and cross protection of algae and cyanobacteria from virus an bacteriophage infections |
| 03/18/2010 | US20100068720 Method and kit for detection of early cancer or pre-cancer using blood and body fluids |
| 03/18/2010 | US20100068719 Cell culture system for determinging the sensitizing, allergenic and/or irritating effect of a substance |